TRADING UPDATES: Billington faces headwinds; Immotion plans spin-off
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read moreMon, 17th Jun 2019 12:21
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more(Sharecast News) - Pharmaceutical and drug delivery technology developer Futura Medical has entered into a licensing agreement with Menarini Korea, it announced on Wednesday, for the exclusive rights to commercialise the company's topical gel-based erectile dysfunction treatment MED3000 in South Korea.
Read more(Alliance News) - Futura Medical PLC shares jumped on Wednesday after the company said it has entered a licensing agreement with A Menarini Korea Ltd or the exclusive rights to commercialise its MED3000 treatment in South Korea.
Read moreTRADING UPDATES: Silver Bullet faces cyber attack; Zoltav to delist
Read more(Sharecast News) - Futura Medical updated the market on regulatory and commercial progress for 'MED3000', its topical gel formulation for the treatment of erectile dysfunction, on Monday.
Read moreEXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group
Read moreEXECUTIVE CHANGES: WH Ireland hires new CFO; Grubhub founder exits JET
Read moreEARNINGS UPDATES: Pittards swings to profit; Immupharma loss widens
Read more(Sharecast News) - Transdermal drug delivery technology company Futura Medical has entered into a licensing agreement with Labatec Pharma, a Switzerland-based specialty pharma company focussed on commercialisation in the Europe and Middle East and North Africa (MENA) regions, it announced on Monday.
Read moreIN BRIEF: Futura Medical teams with Labatec to commercialise MED3000
Read moreUK earnings, trading statements calendar - next 7 days
Read moreIN BRIEF: Futura progressing US regulatory submission for MED3000
Read moreTRADING UPDATES: Sanderson Selfridges deal; Cazoo ups Forward Partners
Read more(Sharecast News) - Futura Medical has entered into a licensing agreement with M8 Pharmaceuticals, a specialty biopharmaceutical company focused on commercialisation in Latin America, for the rights to exclusively develop and commercialise its topical, gel-based erectile dysfunction (ED) treatment MED3000 in Brazil and Mexico, it announced on Tuesday.
Read moreTRADING UPDATES: Sareum raises GBP1 million; Marlowe buys Core Stream
Read more